Essex Woodlands Fund IX, L.P., Ten Percent Owner at AxoGen, holds 3.49M shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 32.04M shares in Venus Concept (Ticker: VERO), holds 3.71M shares in AxoGen (Ticker: AXGN). Most recently, Essex Woodlands Fund IX, L.P. Sold ― shares of EyePoint Pharmaceuticals on Sep 06, 2023 for an estimated value of 197.80K.